Start • Leica Biosystems Aktuelles Leica Biosystems Aktuelles Updates about Leica Biosystems. Filter by post category: Quality Automated Histology Workflow Academic Research Digital Pathology Translational Research Tumor Microenvironment Immunofluorescence Chromogenic multiplexing Automated IHC Cancer Research Research Stainer Digital Spatial RNA Life Science CRO AMC Biotechnology Industry Pharmaceutical Industry Multiplexing High-Plex UltraPlex BOND RX BOND RXm Cell IDx Leica Biosystems Acquires Cell IDx, Moving its Multiplexing Menu Forward with Ready-to-Use, Pre-Kitted FormulationsPublished: 8 November 2022 San Diego, CA – November 8, 2022. Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc., a leader in multiplexed tissue profiling. Founded in 2012 and headquartered in San Diego, California, Cell IDx provides multiplex… Digital Pathology Connections Community Debuts at Pathology Visions 2022Published: 13 October 2022 Pathologists Can Join the Global Community at PathVisions Booth 214 & Online LAS VEGAS, Nev. (Oct. 13, 2022) – Pathologists from Europe, Japan and the United States today jointly announced the debut of Digital Pathology Connections (DPC), a global community for professionals interested in the… Leica Biosystems Finalist for 2022 Victorian Manufacturing Hall of Fame AwardPublished: 29 July 2022 The company’s latest Advanced Staining Solution, BOND-PRIME, is primarily manufactured in Melbourne, Australia MELBOURNE – Leica Biosystems is pleased to announce that the company was a finalist for the 2022 Victorian Manufacturing Hall of Fame Award for Manufacturer of the Year (Large Business).… Accelerate Your Breakthrough Discoveries with Enhanced BOND RX & Nanostring GeoMx Automated RNA Digital Spatial ProfilingPublished: 1 March 2022 SEATTLE, USA and MELBOURNE, AUSTRALIA. March 1st Leica Biosystems continues to advance its relationship with NanoString Technologies Inc., supporting translational research to build confidence in reproducibility and throughput while minimizing manual steps and reducing hands-on time with the… Leica Biosystems Expands its Dual-Retort Tissue Processor Portfolio in North America with HistoCore PEGASUSPublished: 3 February 2022 Solution enables laboratory managers to optimize their tissue processor workflow. NUSSLOCH, GERMANY, FEB 1, 2022. Leica Biosystems is proud to add a new offering to its dualretort tissue processer portfolio: the HistoCore PEGASUS is now available in North American geographies. Building on more than… Leica Biosystems and Leap Therapeutics Partner on Companion Diagnostic to Advance Care for Cancer PatientsPublished: 31 January 2022 CAMBRIDGE, MASS., JANUARY 31, 2022. Companion diagnostic supports patient identification and enrollment into clinical trials of Leap Therapeutics‘ DKK1 inhibitor, DKN-01 Leica Biosystems, a cancer diagnostics company, has entered into an agreement with Leap Therapeutics (Nasdaq: LPTX), a… Pagination « Previous Page 1 Current page 2 Page 3 Page 4 » Next